Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
4.110
-0.090 (-2.14%)
At close: Mar 28, 2025, 4:00 PM
4.214
+0.104 (2.54%)
After-hours: Mar 28, 2025, 5:14 PM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $280.85 million as of March 28, 2025. Its market cap has decreased by -59.82% in one year.
Market Cap
280.85M
Enterprise Value
-151.81M
1-Year Change
-59.82%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $280.85M, a decrease of -84.35%. That is a compound annual growth rate of -34.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 280.85M | -34.70% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.85B |
| UnitedHealth Group | 471.74B |
| Johnson & Johnson | 393.12B |
| AbbVie | 358.61B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.80B |
| AstraZeneca | 225.00B |
| Merck & Co. | 221.28B |